Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
This study is currently recruiting participants.
Study NCT00552149. Last updated on October 31, 2007.
Information provided by Institut Gustave Roussy
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Biliary Cancer
Additional conditions recognized in this trial
Biliary Tract Neoplasms
More general conditions related to this trial
Biliary Tract Diseases
Digestive System Diseases
Digestive System Neoplasms
Neoplasms
Neoplasms by Site
Interventions listed in this trial
Gemox, Cetuximab
Additional drug interventions recognized in this trial
Cetuximab
Gemcitabine
Oxaliplatin
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Institut Gustave Roussy
Merck Serono International SA
Back to top of Main Content